Literature DB >> 24372896

Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view.

Ken-ichi Yamamoto1, Toshikazu Shinba, Mitsunobu Yoshii.   

Abstract

What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti-noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long-term noradrenergic dysfunction.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  hyperarousal symptoms; locus coeruleus; noradrenaline; pathophysiology; stress

Mesh:

Substances:

Year:  2013        PMID: 24372896     DOI: 10.1111/pcn.12126

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  17 in total

1.  Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling.

Authors:  M J Skelly; A E Chappell; E Carter; J L Weiner
Journal:  Neuropharmacology       Date:  2015-06-01       Impact factor: 5.250

Review 2.  Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review.

Authors:  Javier Quintero; José R Gutiérrez-Casares; Cecilio Álamo
Journal:  Neurol Ther       Date:  2022-08-11

Review 3.  Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis.

Authors:  Fumihiko Ueno; Yusuke Iwata; Shinichiro Nakajima; Fernando Caravaggio; Jose M Rubio; Guillermo Horga; Clifford M Cassidy; Edgardo Torres-Carmona; Vincenzo de Luca; Sakiko Tsugawa; Shiori Honda; Sho Moriguchi; Yoshihiro Noda; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Neurosci Biobehav Rev       Date:  2021-10-27       Impact factor: 9.052

Review 4.  Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention.

Authors:  Erica Bell; Phil Boyce; Richard J Porter; Richard A Bryant; Gin S Malhi
Journal:  CNS Drugs       Date:  2021-05-21       Impact factor: 5.749

Review 5.  A Neurophysiological and Neuropsychological Consideration of Mindful Movement: Clinical and Research Implications.

Authors:  Tamara Anne Russell; Silvia Maria Arcuri
Journal:  Front Hum Neurosci       Date:  2015-05-26       Impact factor: 3.169

Review 6.  Executive Dysfunctions: The Role in Attention Deficit Hyperactivity and Post-traumatic Stress Neuropsychiatric Disorders.

Authors:  Lía Martínez; Edward Prada; Corina Satler; Maria C H Tavares; Carlos Tomaz
Journal:  Front Psychol       Date:  2016-08-23

7.  Decreased anxiety after catheter ablation for paroxysmal atrial fibrillation is associated with augmented parasympathetic reactivity to stress.

Authors:  Hideyuki Hasebe; Toshikazu Shinba
Journal:  Heart Rhythm O2       Date:  2020-06-10

8.  Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.

Authors:  Mary J Skelly; Jeff L Weiner
Journal:  Brain Behav       Date:  2014-04-14       Impact factor: 2.708

9.  Resting-State Peripheral Catecholamine and Anxiety Levels in Korean Male Adolescents with Internet Game Addiction.

Authors:  Nahyun Kim; Tonda L Hughes; Chang G Park; Laurie Quinn; In Deok Kong
Journal:  Cyberpsychol Behav Soc Netw       Date:  2016-02-05

Review 10.  A mechanistic model for individualised treatment of anxiety disorders based on predictive neural biomarkers.

Authors:  Anne-Kathrin Brehl; Nils Kohn; Aart Herman Schene; Guillen Fernández
Journal:  Psychol Med       Date:  2020-03-24       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.